DAVID ZICK: Open Payments
NPI 1366480576 · BOWLING GREEN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$906 in 42 payments from 14 companies in 2025. Trend: 2023 $1,471 · 2024 $1,293 · 2025 $906
Food & beverage: $906
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 10 | $186 |
| Neurocrine BioSciences, Inc. | 6 | $139 |
| ABBVIE INC. | 4 | $96 |
| Lundbeck LLC | 4 | $92 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $79 |
| Teva Pharmaceuticals USA, Inc. | 3 | $59 |
| E.R. Squibb & Sons, L.L.C. | 2 | $44 |
| Axsome Therapeutics, Inc. | 2 | $44 |
| Alkermes, Inc. | 2 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $33 |
Products named: REXULTI, INGREZZA, VRAYLAR, CAPLYTA, ABILIFY ASIMTUFII, COBENFY, Auvelity, UZEDY.
Industry payments across OH — which companies pay providers there.
